ChEBI
cyclopropanes
- Term ID
-
CHEBI:51454
- Synonyms
-
- Definition
-
Cyclopropane and its derivatives formed by substitution.
- References
-
- Ontology
-
ChEBI
(
EBI
)
Relationships
- is a type of
-
- has subtype
-
(+)-(1S,2S)-norcoronamic acid
(1,2,3-trimethyl-2-cyclopropen-1-yl)benzene
(2,3-diphenylcyclopropyl)methyl phenyl sulfoxide
(2S,4R)-hypoglycin B
(2S,4S)-hypoglycin B
(22E)-24,26-cyclo-19-norcholesta-1,3,5(10),22-tetraen-3-ol
(R,R)-chrysanthemal
1-(2-methylenecyclopropyl)ethanone
1-bromo-4-cyclopropylbenzene
1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-N-[4-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl]-1,4-dihydroquinoline-3-carboxamide
1-methylidene-2-(pent-4-en-1-yl)cyclopropane
2-(3,5-dichlorophenylcarbamoyl)-1,2-dimethylcyclopropane-1-carboxylic acid
2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione
2-[5-cyclopropyl-3-(ethylsulfonyl)pyridin-2-yl]-5-[(trifluoromethyl)sulfinyl]-1,3-benzoxazole
2-amino-3-(2-methylenecyclopropyl)propanoic acid
2-cyano-3-cyclopropyl-1-(2-mesyl-4-trifluoromethylphenyl)propan-1,3-dione
2-hydroxy-3-(2-methylidenecyclopropyl)butanedioic acid
2-phenylcyclopropan-1-amine
3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide
3-oxociprofloxacin
3beta-hydroxy-9beta-9,19-cyclolanost-24-en-28-oic acid
5-[(2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl]pyrimidine-2,4-diamine
5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate
5alpha,8alpha-epidioxysterol
12-hydroxynevirapine
26,27-dehydrozymosterol
aminocyclopyrachlor
apinocaltamide
BAY 41-2272
BAY 60-6583
beta-(methylenecyclopropyl)pyruvic acid
bexagliflozin
brevipolide A
brevipolide B
calcipotriol
chrysanthemic acid
chrysanthemol
ciprofibrate
ciprofloxacin
coprine
cyclanilide
cyclopropane
cyclopropanecarboxylate ester
cyclopropanecarboxylic acid
cyclopropanol
cyclopropylcarboxamide
cyclopyrimorate
cyprodinil
cyproflanilide
cyprosulfamide
E-3810 free base
efavirenz
enrofloxacin
epsilon-metofluthrin
epsilon-momfluorothrin
ethyl 1-allylcyclopropanecarboxylate
finafloxacin
firocoxib
flucycloxuron
foretinib
FR171456
garenoxacin
grazoprevir
GSK2879552
heptafluthrin
imiprothrin
indazapyroxamet
irgarol 1051
isoflucypram
isoxaflutole
jawsamycin
kappa-bifenthrin
L-alpha-(methylidenecyclopropyl)glycine
lenvatinib
lesinurad
lumacaftor
methyl cyclopropanecarboxylate
MLI-2
moxifloxacin
N-(2-[(2-aminoethyl)(methyl)amino]-5-{[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino}phenyl)acetamide
N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide
N-cyclopropyl-3-{4-[(cyclopropylmethyl)carbamoyl]phenyl}-4-methylbenzamide
N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydropyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide
N-cyclopropyl-4-[4-(3,4-dichlorophenyl)-2-(1-methylpiperidin-4-yl)-1-propylimidazol-5-yl]pyrimidin-2-amine
N-{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide
N-{3-[(5-cyclopropyl-2-{[3-methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)amino]propyl}cyclobutanecarboxamide
naltrexone
narlaprevir
nevirapine
olaparib
paritaprevir
permethrin
PHA-533533
pitavastatin
prallethrin
remikiren
roflumilast
SCH-79797
SGC-CK2-1
sulfociprofloxacin
TA-1887
tasimelteon
tedisamil
telaprevir
tert-butyl N-{1-[(1S)-1-{[(1R,2S)-1-(benzylcarbamoyl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]carbamoyl}-2-cyclopropylethyl]-2-oxopyridin-3-yl}carbamate
Toblerol C
tralomethrin
trametinib
transfluthrin
trinexapac
trinexapac-ethyl
vaniprevir
volasertib
Show first 5 Terms
Phenotype
Phenotype resulting from cyclopropanes
Phenotype where environments contain cyclopropanes
Phenotype modified by environments containing cyclopropanes
Human Disease / Model Data